HIV
Conference Coverage
Injecting long-acting antiretrovirals into clinic care
In the peer staff program, workers are trained in a 4-month medical residency–style program that shows them how to test for HIV, inject long-...
Conference Coverage
UNAIDS targets: Progress reported, but ‘HIV is far from over’
New infections persist at a rate that has not dropped as fast as possible.
Conference Coverage
Low HIV levels linked to ‘almost zero’ risk of sexual transmission
“This [finding] provides a powerful opportunity to help destigmatize HIV, promote the benefits of adhering to antiretroviral therapy, and support...
Conference Coverage
Daily statin cuts cardiovascular risk in HIV
“These are types of people who, if they came to the doctor’s office right now before REPRIEVE, they would largely be told your risk score is not...
Conference Coverage
Long-acting ART effective without viral suppression
“Instead of having the burden of taking a pill every day, patients with HIV can now have these choices of being able to forget about their...
News
Doxy PEP does not lower risk of STIs in cisgender women
Women are known to be at higher risk of infection because the lining of the vagina is thinner than the skin of the penis, allowing for easier...
News
Scientists create ‘vagina on a chip’: What to know
Researchers see the chip as a way to facilitate vaginal health research and open the door to vital new treatments.
News
Highly anticipated HIV vaccine fails in large trial
The vaccine had been in development since 2019 and was given to 3,900 study participants through October 2022.
News
FDA approves first-in-class drug for HIV
FDA has approved the medication lenacapavir (Sunlenca) for adults living with multidrug resistant HIV-1 infection.
News
Systematic review supports preferred drugs for HIV in youths
Findings support the use of dolutegravir an raltegravir as part of WHO-recommended regimens for treating HIV.